183 related articles for article (PubMed ID: 20200429)
21. Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women.
Nagata C; Matsubara T; Hara T; Fujita H; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2509-12. PubMed ID: 18006946
[TBL] [Abstract][Full Text] [Related]
22. Urinary melatonin and risk of ovarian cancer.
Poole EM; Schernhammer E; Mills L; Hankinson SE; Tworoger SS
Cancer Causes Control; 2015 Oct; 26(10):1501-6. PubMed ID: 26223889
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of urinary melatonin in women and its relation to other hormones and night work.
Schernhammer ES; Rosner B; Willett WC; Laden F; Colditz GA; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):936-43. PubMed ID: 15184249
[TBL] [Abstract][Full Text] [Related]
25. Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis.
Xu J; Huang L; Sun GP
Sci Rep; 2017 Jul; 7(1):5353. PubMed ID: 28706222
[TBL] [Abstract][Full Text] [Related]
26. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
[TBL] [Abstract][Full Text] [Related]
27. Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study.
Saksvik-Lehouillier I; Harrison SL; Marshall LM; Tranah GJ; Ensrud K; Ancoli-Israel S; Clemons A; Redline S; Stone KL; Schernhammer ES;
J Gerontol A Biol Sci Med Sci; 2015 Dec; 70(12):1569-77. PubMed ID: 26265731
[TBL] [Abstract][Full Text] [Related]
28. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
29. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
[TBL] [Abstract][Full Text] [Related]
30. First-morning urinary melatonin and breast cancer risk in the Guernsey Study.
Wang XS; Tipper S; Appleby PN; Allen NE; Key TJ; Travis RC
Am J Epidemiol; 2014 Mar; 179(5):584-93. PubMed ID: 24418683
[TBL] [Abstract][Full Text] [Related]
31. Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women.
Lee JY; Kim JH; Lee DC
Menopause; 2014 Jan; 21(1):39-44. PubMed ID: 23760432
[TBL] [Abstract][Full Text] [Related]
32. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
[TBL] [Abstract][Full Text] [Related]
33. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
34. Lactation and a reduced risk of premenopausal breast cancer.
Newcomb PA; Storer BE; Longnecker MP; Mittendorf R; Greenberg ER; Clapp RW; Burke KP; Willett WC; MacMahon B
N Engl J Med; 1994 Jan; 330(2):81-7. PubMed ID: 8259187
[TBL] [Abstract][Full Text] [Related]
35. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Schernhammer ES; Sperati F; Razavi P; Agnoli C; Sieri S; Berrino F; Krogh V; Abbagnato C; Grioni S; Blandino G; Schunemann HJ; Muti P
Breast Cancer Res; 2013 Jun; 15(3):R46. PubMed ID: 23777922
[TBL] [Abstract][Full Text] [Related]
36. Sleep duration, melatonin and breast cancer among Chinese women in Singapore.
Wu AH; Wang R; Koh WP; Stanczyk FZ; Lee HP; Yu MC
Carcinogenesis; 2008 Jun; 29(6):1244-8. PubMed ID: 18448486
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
38. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
[TBL] [Abstract][Full Text] [Related]
39. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
[TBL] [Abstract][Full Text] [Related]
40. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
Anderson LN; Cotterchio M; Boucher BA; Kreiger N
Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]